Cited by 134Schizophrenia research and treatmentBioinformatics and Genomic NetworksAutism Spectrum Disorder Research

Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia

Open access
Torkamani, Ali, Dean, Brian, Schork, Nicholas J., Thomas, Elizabeth A.·2010·Genome Research

Abstract

We performed integrated gene coexpression network analysis on two large microarray-based brain gene expression data sets generated from the prefrontal cortex obtained post-mortem from 101 subjects, 47 subjects with schizophrenia and 54 normal control subjects, ranging in age from 19 to 81 years. Twenty-eight modules of coexpressed genes with functional interpretations were detected in both normal subjects and those with schizophrenia. Significant overlap of “case” and “control” module composition was observed, indicating that extensive differences in underlying molecular connectivity are not likely driving pathology in schizophrenia. Modules of coexpressed genes were characterized according to disease association, cell type specificity, and the effects of aging. We find that genes with altered expression in schizophrenia clustered into distinct coexpression networks and that these were associated primarily with neurons. We further identified a robust effect of age on gene expression modules that differentiates normal subjects from those with schizophrenia. In particular, we report that normal age-related decreases in genes related to central nervous system developmental processes, including neurite outgrowth, neuronal differentiation, and dopamine-related cellular signaling, do not occur in subjects with schizophrenia during the aging process. Extrapolating these findings to earlier stages of development supports the concept that schizophrenia pathogenesis begins early in life and is associated with a failure of normal decreases in developmental-related gene expression. These findings provide a novel mechanism for the “developmental” hypothesis of schizophrenia on a molecular level.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gr.101956.109

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GBA approaches are widely used to identify new potential disease genes if a substantial proportion of the genes within a module are associated with a particular disease.

    “GBA approaches are also widely used to identify new potential disease genes if a substantial proportion of the genes within a module are associated with a particular disease [26, 121–126] (Figure 1).”

    From Gene co-expression analysis for functional classification and gene–disease predictions (2017) · cites this paper as [123]

    The Discussion describes using module membership for guilt-by-association to infer the functions of new genes, and the disease-association section compares modules with previously identified schizophrenia-associated genes. It does not establish that this approach is widely used to identify new potential disease genes when a substantial proportion of a module’s genes are disease-associated. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • One of the first studies to put schizophrenia transcriptomics into a genome-wide co-expression network used mutual information and WGCNA.

    “One of the first studies to put schizophrenia transcriptomics into a genome-wide co-expression network used mutual information and WGCNA107.”
  • That study showed that in schizophrenia, as in ASD, the overall transcriptomic structure in control brains is intact, but a neural differentiation module associated with schizophrenia does not follow the normal trajectory of downregulation with age.

    “This study showed that, as in ASD, the overall transcriptomic structure that is observed in control brains is intact but that a neural differentiation module that is associated with schizophrenia does not follow the normal trajectory of downregulation with age.”
  • Gene co-expression was organized into modules of distinct cellular and functional categories, consistent with prior brain transcriptome studies.

    “Consistent with prior studies of the brain transcriptome15,47–50, we find gene co-expression to be organized into modules of distinct cellular and functional categories (Supplementary data file 7).”
  • Gene co-expression is organized into modules of distinct cellular and functional categories.

    “Consistent with prior studies of the brain transcriptome15,47–50, we find gene co-expression to be organized into modules of distinct cellular and functional categories (Supplementary data file 7).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 47 · Cited by 134

Authors
Torkamani, A., Dean, B., Schork, N. J., & Thomas, E. A.
Affiliations
  • Mental Health Research Institute (AU)
  • Scripps Research Institute (US)
Venue
Genome Research
Published
2010-03-02
Volume
20
Issue
4
Pages
403-412
ISSN
1088-9051 (ISSN-L)
OpenAlex
W2171927996
Cited by
134
References
47
Citations by year
2026: 2 · 2025: 1 · 2023: 3 · 2022: 8 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 10 · 2017: 5 · 2016: 15 · 2015: 12 · 2014: 13 · 2013: 8 · 2012: 20
Type
posted content
Language
en
Open access
Locations
  • Genome Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health (MH069696)
  • National Health and Medical Research Council (400016)
  • National Institute of Mental Health (R01MH069696, MH069696)
  • National Center for Research Resources (UL1RR025774, U54RR02504-01)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
schizophrenia, gene co-expression network, prefrontal cortex, postmortem brain, aging, neuronal differentiation, neurite outgrowth, dopamine signaling, gene modules, neural development
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Female, Humans, Male, Middle Aged, Nervous System, Schizophrenia, Case-Control Studies, Prefrontal Cortex, Gene Expression Regulation, Developmental, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Gene Regulatory Networks, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review